| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,961 |
24,853 |
$6.07M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,692 |
13,067 |
$3.68M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,442 |
12,597 |
$2.92M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,249 |
4,093 |
$2.30M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
10,230 |
8,093 |
$1.63M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,452 |
1,987 |
$1.59M |
| G0378 |
Hospital observation service, per hour |
9,854 |
3,031 |
$1.53M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,716 |
5,192 |
$1.20M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14,447 |
10,532 |
$1.08M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,683 |
3,435 |
$1.03M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60,862 |
38,296 |
$882K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,780 |
4,409 |
$861K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,637 |
8,220 |
$836K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,564 |
12,963 |
$745K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,456 |
11,149 |
$667K |
| 80053 |
Comprehensive metabolic panel |
50,106 |
34,384 |
$599K |
| 71045 |
Radiologic examination, chest; single view |
15,561 |
11,421 |
$539K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,665 |
6,386 |
$501K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,266 |
5,749 |
$463K |
| 0240U |
|
2,241 |
2,047 |
$435K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,410 |
2,885 |
$423K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,481 |
3,806 |
$386K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,719 |
1,037 |
$377K |
| 36415 |
Collection of venous blood by venipuncture |
80,761 |
50,364 |
$348K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,165 |
4,049 |
$321K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,967 |
3,852 |
$298K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,737 |
1,358 |
$273K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,366 |
2,705 |
$264K |
| 84484 |
|
15,272 |
9,546 |
$259K |
| 83690 |
|
13,309 |
9,072 |
$259K |
| 81001 |
|
24,981 |
17,201 |
$212K |
| 87631 |
|
1,833 |
1,217 |
$210K |
| 84703 |
|
7,638 |
5,634 |
$201K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
532 |
385 |
$186K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,869 |
2,788 |
$174K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,892 |
1,061 |
$161K |
| 83735 |
|
20,607 |
11,371 |
$150K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,572 |
2,111 |
$147K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,589 |
1,663 |
$142K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,370 |
864 |
$133K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
673 |
389 |
$127K |
| 93975 |
|
1,118 |
676 |
$124K |
| 87070 |
|
5,169 |
3,666 |
$114K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,483 |
1,181 |
$114K |
| 71046 |
Radiologic examination, chest; 2 views |
9,098 |
6,100 |
$112K |
| 80061 |
Lipid panel |
10,555 |
7,605 |
$110K |
| 80050 |
General health panel |
3,085 |
2,180 |
$100K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,408 |
6,213 |
$99K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,292 |
4,544 |
$98K |
| 82550 |
|
12,477 |
8,400 |
$96K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
738 |
470 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,677 |
2,053 |
$92K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,743 |
4,769 |
$87K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
729 |
585 |
$85K |
| 85730 |
|
12,835 |
7,992 |
$84K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,664 |
8,812 |
$84K |
| 83880 |
|
3,391 |
1,888 |
$83K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,005 |
1,354 |
$81K |
| 76830 |
Ultrasound, transvaginal |
1,823 |
1,222 |
$79K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,569 |
2,739 |
$76K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,381 |
1,046 |
$74K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,303 |
1,055 |
$74K |
| 93971 |
|
1,187 |
731 |
$73K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
986 |
511 |
$73K |
| 93970 |
|
578 |
366 |
$69K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,974 |
1,846 |
$68K |
| 93017 |
|
1,063 |
559 |
$63K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,223 |
1,151 |
$63K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,567 |
1,844 |
$62K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,465 |
1,075 |
$53K |
| 96376 |
|
1,675 |
881 |
$52K |
| 87040 |
|
3,267 |
1,693 |
$51K |
| 84439 |
|
3,619 |
2,409 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,260 |
1,421 |
$49K |
| 59025 |
Fetal non-stress test |
211 |
177 |
$49K |
| 76801 |
|
1,254 |
731 |
$49K |
| 81025 |
|
5,570 |
2,988 |
$47K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,818 |
444 |
$47K |
| 85610 |
|
15,559 |
9,330 |
$46K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,295 |
571 |
$46K |
| 86140 |
|
5,059 |
3,590 |
$44K |
| 82553 |
|
4,436 |
2,579 |
$43K |
| 71250 |
|
482 |
347 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,259 |
1,420 |
$42K |
| 85379 |
|
2,318 |
1,348 |
$40K |
| 85027 |
|
6,928 |
4,113 |
$40K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
148 |
88 |
$39K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
274 |
233 |
$39K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,041 |
719 |
$38K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,064 |
638 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,377 |
997 |
$37K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
798 |
515 |
$37K |
| J2785 |
Injection, regadenoson, 0.1 mg |
800 |
441 |
$35K |
| J2704 |
Injection, propofol, 10 mg |
6,013 |
2,338 |
$33K |
| 87486 |
|
465 |
362 |
$32K |
| J1756 |
Injection, iron sucrose, 1 mg |
161 |
67 |
$31K |
| 84702 |
|
1,622 |
927 |
$30K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
618 |
130 |
$29K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
253 |
81 |
$29K |
| 73564 |
|
1,950 |
1,137 |
$28K |
| 94664 |
|
1,954 |
872 |
$28K |
| J3490 |
Unclassified drugs |
6,808 |
2,298 |
$27K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
455 |
364 |
$26K |
| 83605 |
|
3,405 |
1,770 |
$25K |
| 70486 |
|
209 |
148 |
$24K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
435 |
293 |
$24K |
| 82728 |
|
2,008 |
1,336 |
$23K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,012 |
521 |
$23K |
| 88342 |
|
440 |
209 |
$22K |
| 97803 |
|
1,782 |
810 |
$22K |
| 73610 |
|
1,298 |
831 |
$22K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
811 |
563 |
$21K |
| 73130 |
|
1,650 |
963 |
$21K |
| 73630 |
|
1,822 |
1,078 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,210 |
2,092 |
$20K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,269 |
695 |
$20K |
| 84100 |
|
5,627 |
2,504 |
$20K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,725 |
803 |
$19K |
| 82962 |
|
9,163 |
3,199 |
$19K |
| 94760 |
|
3,158 |
785 |
$19K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,279 |
1,442 |
$18K |
| 86850 |
|
2,534 |
1,441 |
$17K |
| 73030 |
|
1,550 |
944 |
$17K |
| 87077 |
|
2,417 |
1,513 |
$17K |
| 93225 |
|
219 |
118 |
$17K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
574 |
218 |
$17K |
| 76770 |
|
407 |
301 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,376 |
5,989 |
$16K |
| 85652 |
|
4,051 |
2,868 |
$16K |
| 84466 |
|
1,281 |
933 |
$16K |
| 82607 |
|
1,161 |
750 |
$16K |
| 86901 |
|
2,834 |
1,643 |
$16K |
| 99222 |
Initial hospital care, per day, moderate complexity |
335 |
211 |
$16K |
| 87186 |
|
2,144 |
1,287 |
$14K |
| 73110 |
|
1,208 |
708 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
275 |
222 |
$13K |
| 76820 |
|
538 |
309 |
$13K |
| 82043 |
|
1,733 |
1,201 |
$13K |
| 86900 |
|
2,612 |
1,485 |
$13K |
| 90715 |
|
1,231 |
655 |
$13K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,351 |
1,278 |
$13K |
| 83540 |
|
1,567 |
1,132 |
$12K |
| S9083 |
Global fee urgent care centers |
243 |
192 |
$12K |
| 99215 |
Prolong outpt/office vis |
113 |
98 |
$12K |
| 76536 |
|
292 |
210 |
$12K |
| 80076 |
|
2,328 |
1,509 |
$12K |
| 82570 |
|
2,217 |
1,546 |
$12K |
| 87581 |
|
465 |
362 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,352 |
991 |
$11K |
| 76642 |
|
816 |
475 |
$11K |
| 87634 |
|
108 |
107 |
$11K |
| 87507 |
|
69 |
56 |
$10K |
| 86803 |
|
562 |
352 |
$10K |
| 93226 |
|
134 |
65 |
$10K |
| 82803 |
|
681 |
395 |
$10K |
| 96367 |
|
210 |
113 |
$9K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
423 |
315 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,615 |
2,293 |
$9K |
| 73502 |
|
768 |
534 |
$9K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
1,146 |
428 |
$8K |
| 74018 |
|
1,026 |
668 |
$8K |
| 84145 |
|
271 |
232 |
$8K |
| 82746 |
|
403 |
267 |
$8K |
| 36591 |
|
1,565 |
471 |
$8K |
| 84436 |
|
1,361 |
882 |
$8K |
| 83874 |
|
2,654 |
1,561 |
$7K |
| G0416 |
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method |
13 |
12 |
$7K |
| 72100 |
|
755 |
525 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,483 |
1,005 |
$7K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
17 |
13 |
$7K |
| 97161 |
|
394 |
219 |
$6K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,307 |
339 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,210 |
1,884 |
$5K |
| 84479 |
|
817 |
520 |
$5K |
| 82150 |
|
1,450 |
771 |
$5K |
| 87205 |
|
1,266 |
698 |
$5K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$5K |
| 86038 |
|
499 |
216 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,114 |
812 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,916 |
3,947 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,869 |
6,017 |
$4K |
| 72110 |
|
548 |
389 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
228 |
156 |
$4K |
| 82248 |
|
544 |
334 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,226 |
650 |
$4K |
| 99205 |
Prolong outpt/office vis |
33 |
26 |
$4K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
308 |
62 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
51 |
43 |
$4K |
| 94060 |
|
157 |
87 |
$4K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
38 |
37 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
20 |
13 |
$4K |
| 80074 |
|
88 |
63 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
76 |
26 |
$4K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
355 |
168 |
$3K |
| J3480 |
Injection, potassium chloride, per 2 meq |
594 |
195 |
$3K |
| 73590 |
|
267 |
99 |
$3K |
| 87340 |
|
570 |
343 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
86 |
72 |
$3K |
| 10060 |
|
144 |
76 |
$3K |
| 83615 |
|
365 |
210 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
636 |
325 |
$3K |
| 97165 |
|
131 |
78 |
$2K |
| 73080 |
|
185 |
124 |
$2K |
| 83970 |
|
29 |
24 |
$2K |
| 87210 |
|
464 |
311 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
33 |
28 |
$2K |
| 36600 |
|
287 |
155 |
$2K |
| 80069 |
|
251 |
146 |
$2K |
| 84550 |
|
598 |
349 |
$2K |
| 99221 |
|
117 |
95 |
$2K |
| 86780 |
|
125 |
92 |
$2K |
| 73140 |
|
154 |
83 |
$2K |
| 87147 |
|
407 |
248 |
$2K |
| 77066 |
Tomosynthesis, mammo |
48 |
41 |
$2K |
| 77065 |
Tomosynthesis, mammo |
115 |
70 |
$2K |
| 73562 |
|
131 |
81 |
$2K |
| 84156 |
|
247 |
150 |
$2K |
| 72050 |
|
49 |
37 |
$2K |
| 12001 |
|
98 |
65 |
$2K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
15 |
12 |
$1K |
| 29125 |
|
23 |
12 |
$1K |
| 86592 |
|
308 |
158 |
$1K |
| 83655 |
|
98 |
63 |
$1K |
| 94729 |
|
68 |
40 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,063 |
871 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
2,029 |
758 |
$1K |
| J1630 |
Injection, haloperidol, up to 5 mg |
106 |
53 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,664 |
1,211 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
631 |
199 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
25 |
13 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
156 |
90 |
$999.89 |
| 90686 |
|
206 |
85 |
$996.26 |
| 82272 |
|
193 |
159 |
$964.43 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
876 |
137 |
$920.94 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
77 |
36 |
$839.87 |
| 73090 |
|
43 |
28 |
$766.39 |
| 80143 |
|
34 |
28 |
$730.42 |
| 80179 |
|
34 |
28 |
$730.42 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,021 |
1,065 |
$724.92 |
| 99233 |
Prolong inpt eval add15 m |
19 |
14 |
$676.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
358 |
43 |
$669.92 |
| 85018 |
|
451 |
259 |
$642.18 |
| 86762 |
|
103 |
67 |
$574.62 |
| 84460 |
|
51 |
36 |
$562.85 |
| 70491 |
|
21 |
13 |
$557.35 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
512 |
15 |
$544.45 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
37 |
14 |
$507.29 |
| C1753 |
Catheter, intravascular ultrasound |
265 |
33 |
$493.54 |
| 82565 |
|
120 |
68 |
$491.56 |
| 85014 |
|
334 |
179 |
$464.94 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
69 |
67 |
$460.76 |
| 96523 |
|
17 |
13 |
$386.70 |
| 73552 |
|
59 |
38 |
$336.09 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
368 |
173 |
$235.40 |
| J3411 |
Injection, thiamine hcl, 100 mg |
44 |
24 |
$230.73 |
| 82009 |
|
162 |
97 |
$204.65 |
| 97162 |
|
32 |
13 |
$172.56 |
| 85007 |
|
13 |
12 |
$135.97 |
| 94799 |
|
61 |
24 |
$119.25 |
| 85045 |
|
33 |
26 |
$115.43 |
| 86618 |
|
76 |
52 |
$96.64 |
| 87522 |
Neg quan hep c or qual rna |
19 |
15 |
$93.30 |
| 88307 |
|
39 |
16 |
$87.96 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
66 |
38 |
$87.59 |
| J7510 |
Prednisolone oral, per 5 mg |
421 |
229 |
$54.64 |
| 72072 |
|
41 |
30 |
$47.64 |
| 86431 |
|
35 |
16 |
$34.19 |
| 74022 |
|
105 |
54 |
$28.87 |
| 82270 |
|
101 |
66 |
$27.30 |
| 82247 |
|
24 |
12 |
$24.28 |
| 82950 |
|
19 |
14 |
$10.32 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
7,998 |
5,642 |
$7.22 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
266 |
85 |
$0.02 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
185 |
84 |
$0.01 |
| 85041 |
|
15 |
15 |
$0.00 |
| 84520 |
|
84 |
43 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
44 |
30 |
$0.00 |
| 86308 |
|
26 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
45 |
12 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
45 |
12 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
54 |
12 |
$0.00 |
| 83021 |
|
15 |
15 |
$0.00 |
| 72040 |
|
14 |
13 |
$0.00 |
| 73560 |
|
41 |
27 |
$0.00 |